236.78
前日終値:
$239.83
開ける:
$240.7
24時間の取引高:
264.14K
Relative Volume:
0.27
時価総額:
$14.86B
収益:
$4.44B
当期純損益:
$29.49M
株価収益率:
-12,868.48
EPS:
-0.0184
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
-0.12%
1か月 パフォーマンス:
+20.68%
6か月 パフォーマンス:
+34.05%
1年 パフォーマンス:
+119.45%
Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile
名前
Jazz Pharmaceuticals Plc
セクター
電話
353-1-634-7800
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Compare JAZZ vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
JAZZ
Jazz Pharmaceuticals Plc
|
236.84 | 15.05B | 4.44B | 29.49M | 1.19B | -0.0184 |
|
VRTX
Vertex Pharmaceuticals Inc
|
436.36 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
|
REGN
Regeneron Pharmaceuticals Inc
|
636.51 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
|
ARGX
Argen X Se Adr
|
809.34 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
296.42 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
|
RVMD
Revolution Medicines Inc
|
153.76 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-10 | 再開されました | Raymond James | Outperform |
| 2026-02-27 | 開始されました | Barclays | Overweight |
| 2025-11-24 | ダウングレード | UBS | Buy → Neutral |
| 2025-07-15 | 開始されました | Deutsche Bank | Buy |
| 2025-03-07 | アップグレード | UBS | Neutral → Buy |
| 2025-02-26 | ダウングレード | Cantor Fitzgerald | Overweight → Neutral |
| 2025-02-13 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-12-12 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-05 | 開始されました | Goldman | Buy |
| 2024-01-03 | 開始されました | Robert W. Baird | Outperform |
| 2023-11-27 | ダウングレード | UBS | Buy → Neutral |
| 2023-09-29 | 開始されました | Raymond James | Mkt Perform |
| 2023-06-12 | 再開されました | Wells Fargo | Equal Weight |
| 2022-12-09 | アップグレード | Goldman | Neutral → Buy |
| 2022-06-14 | 開始されました | UBS | Buy |
| 2022-04-06 | ダウングレード | Goldman | Buy → Neutral |
| 2021-11-19 | 再開されました | Goldman | Buy |
| 2021-10-07 | 再開されました | Jefferies | Buy |
| 2021-10-05 | 開始されました | Citigroup | Buy |
| 2021-09-23 | 開始されました | Needham | Buy |
| 2021-05-19 | 再開されました | JP Morgan | Overweight |
| 2021-04-07 | 再開されました | RBC Capital Mkts | Outperform |
| 2021-02-05 | 繰り返されました | H.C. Wainwright | Buy |
| 2021-02-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2021-01-29 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-16 | 開始されました | UBS | Buy |
| 2020-11-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-10-09 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-09-14 | ダウングレード | Goldman | Neutral → Sell |
| 2020-09-14 | 再開されました | JP Morgan | Overweight |
| 2020-08-06 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-07-28 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2020-07-23 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2020-04-06 | 開始されました | Jefferies | Buy |
| 2020-03-12 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-01-08 | 開始されました | Goldman | Neutral |
| 2019-08-21 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2019-06-11 | 開始されました | Barclays | Overweight |
| 2019-03-20 | 開始されました | SunTrust | Buy |
| 2018-12-14 | 開始されました | Wolfe Research | Peer Perform |
| 2018-11-08 | 繰り返されました | B. Riley FBR | Buy |
| 2018-08-08 | 繰り返されました | Stifel | Buy |
| 2018-07-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2018-03-23 | 繰り返されました | H.C. Wainwright | Neutral |
| 2018-03-19 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
すべてを表示
Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース
Narcolepsy Market Trends, Innovation, and Future Growth Outlook to 2034 – DelveInsight | Taisho Pharmaceutical, Jazz Pharma, Suven Life Sciences Limited, Alza Corporation, Cephalon, Orphan Medical - Barchart.com
Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Promising Pipeline Propel Growth Potential - DirectorsTalk Interviews
Jazz, AstraZeneca, Astellas: Foreign healthcare's strongest quant picks - MSN
Banking giant massively resets Jazz Pharma stock price target - AOL.com
Assessing Jazz Pharmaceuticals (JAZZ) Valuation After Its Recent Share Price Momentum - Yahoo Finance
JAZZ Maintained by Piper Sandler -- Price Target Raised to $301 - GuruFocus
[144] Jazz Pharmaceuticals plc SEC Filing - Stock Titan
Proposed sale: JAZZ (NASDAQ) 2,000 shares listed for $482,000 on 05/22/2026 - Stock Titan
JAZZ Initiates Coverage On Bernstein -- Rating Set to Market Per - GuruFocus
Piper Sandler raises Jazz Pharmaceuticals stock price target on zanidatamab outlook By Investing.com - Investing.com South Africa
Morgan Stanley Raises its Price Target on Jazz Pharmaceuticals (JAZZ) - Insider Monkey
Bernstein initiates coverage of Jazz Pharmaceuticals (JAZZ) with market perform recommendation - MSN
UBS Just Upgraded Jazz Pharma to Buy. New $307 Price Target Could Signal a Turning Point - AOL.com
Jazz Pharmaceuticals (JAZZ) Coverage Initiated with Caution by B - GuruFocus
How Investors Are Reacting To Jazz Pharmaceuticals (JAZZ) Reaffirmed Guidance And Rare-Disease Portfolio Momentum - simplywall.st
Jazz Pharma raised to Buy at UBS on Ziihera potential - MSN
Jazz Pharmaceuticals stock hits all-time high at $241.00 By Investing.com - Investing.com Australia
Jazz Pharmaceuticals stock hits all-time high at $241.00 - Investing.com India
10 Best European Growth Stocks to Buy - Insider Monkey
JAZZ Upgraded by UBS -- Price Target Raised to $307 - GuruFocus
Jazz Pharmaceuticals (JAZZ) Upgraded to Buy by UBS with Target P - GuruFocus
UBS upgrades Jazz Pharmaceuticals stock rating on Ziihera potential By Investing.com - Investing.com Nigeria
StubHub, Jazz Pharmaceuticals upgraded: Wall Street's top analyst calls - Yahoo Finance
Here Are Tuesday’s Top Wall Street Analyst Research Calls: American Tower, Citigroup, CrowdStrike, Fortinet, Hanover Insurance, Jazz Pharmaceuticals, Stubhub, X-Energy, and More - Yahoo Finance
Jazz Pharmaceuticals PLC at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
JAZZ Technical Analysis | Trend, Signals & Chart Patterns | JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ) - ChartMill
Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings Signal Promising Growth Potential - DirectorsTalk Interviews
A Look At Jazz Pharmaceuticals (JAZZ) Valuation After Strong Q1 Earnings And Upcoming FDA And Study Catalysts - simplywall.st
Jazz Pharmaceuticals PLC $JAZZ Shares Sold by VIRGINIA RETIREMENT SYSTEMS ET Al - MarketBeat
Swedbank AB Increases Stock Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
JAZZ Stock Jumps as Q1 Earnings & Sales Surpass Expectations - MSN
Truist Financial Corp Has $1.86 Million Holdings in Jazz Pharmaceuticals PLC $JAZZ - MarketBeat
Jazz Pharmaceuticals’s Q1 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
Jazz Pharmaceuticals stock hits all-time high at $230.85 By Investing.com - Investing.com South Africa
Jazz Pharmaceuticals stock hits all-time high at $230.85 - Investing.com
Does Epidiolex Make Jazz Pharmaceuticals a Unique Cannabis Stock? - TradingView
We Think You Can Look Beyond Jazz Pharmaceuticals' (NASDAQ:JAZZ) Lackluster Earnings - simplywall.st
Some Investors May Be Willing To Look Past Jazz Pharmaceuticals' (NASDAQ:JAZZ) Soft Earnings - Yahoo Finance
Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewswire Inc.
Here’s What Analysts Are Saying About Jazz Pharmaceuticals (JAZZ) Post Q1 Results - Insider Monkey
Three Jazz Pharmaceuticals investor webcasts set for May–June 2026 - Stock Titan
Jazz Pharmaceuticals Plc (JAZZ) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):